COCOPREV
- Funded by Agence nationale de recherche sur le sida et les hépatites virale [National Agency for AIDS Research] (ANRS)
- Total publications:0 publications
Grant number: ANRS0003s
Grant search
Key facts
Disease
COVID-19Start & end year
20212024Known Financial Commitments (USD)
$8,462,159.73Funder
Agence nationale de recherche sur le sida et les hépatites virale [National Agency for AIDS Research] (ANRS)Principal Investigator
Yordanov YuriResearch Location
99Lead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Prophylactic use of treatmentsSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Not applicableBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
COCOPREV cohort This is a prospective, multicentre, non-comparative national cohort which studied the efficacy of monoclonal antibodies in preventing severe manifestations of COVID-19 in a cohort of patients at high risk of progressing to a severe form of the disease.